Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Sev… (NCT02432742) | Clinical Trial Compass
CompletedNot Applicable
Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds
China100 participantsStarted 2015-05
Plain-language summary
The purpose of this study is to determine the safety and efficacy of using Restylane Perlane compared to Restylane for correction of moderate to severe nasolabial folds (NLF) in a Chinese population.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Chinese origin
* Subjects intent to undergo correction of both NLFs with a Wrinkle Severity Rating Scale (WSRS) of 3 on both side or 4 on both side.
* Subjects willing to abstain from other facial plastic surgical or cosmetic procedures during the study period.
* Singed Informed Consent
Exclusion Criteria:
* Subjects with traumatic scars or ongoing active skin disease in the area to be treated
* Permanent inplant or filler, including fat injection placed in the area to be treated
* Previous tissue augmentation therapy in the NLFs with non-permanent filler within 12 months prior to inclusion
* Any medical condition in the opinion of the treating investigator who will make the subject unsuitable for inclusion
What they're measuring
1
Mean Change From Baseline in Wrinkle Severity Rating Scale (WSRS) at 6 Months